Business, energy, technology, markets and global industry news from Business News Today

Front Range Pharmaceuticals

PharmaDeviceNews Front Range Pharmaceuticals
A clinician performs a nasal swab beside a compact molecular testing system as AMDI’s sub-10-minute Fast PCR platform targets faster influenza, RSV and COVID-19 diagnosis in urgent-care settings. Representative image.
Pharma & Biotech

FDA Fast Track for FRP-003: Can Front Range Pharmaceuticals tackle Long COVID fatigue?

Front Range wins FDA Fast Track for FRP-003 in Long COVID. Discover what its 220-patient Phase 2 trial must prove.

Read More